Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 19
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Conserving California Red-Legged Frogs

    "My goal is to help protect California's natural legacy in an increasingly modified landscape, with the...

    Does insecticide exposure affect solitary bee nesting behavior?

    Alfalfa leafcutter bees (ALBs) are important crop pollinators that nest in aboveground cavities (e.g. straws...

    Why do wolverines need snow?

    A warming climate in the Arctic is having profound impacts on species that rely on snow and ice, like the...

    Backer Badge Funded